Author:
Kang Jung Mook,Choi Yonghoon
Publisher
Springer Nature Singapore
Reference85 articles.
1. Peek RM Jr, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol. 2006;208:233–48.
2. Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and genetic polymorphism: factors that modulate disease risk. Clin Microbiol Rev. 2010;23:713–39.
3. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002;123:1793–803.
4. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398–402.
5. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Inaba T, et al. Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. Am J Gastroenterol. 2003;98:2403–8.